{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T16:41:45Z","timestamp":1781800905896,"version":"3.54.5"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Joint Scientific Research Fund Project for Public Hospitals in Inner Mongolia Autonomous Region, China","award":["2024GLLH0480,2024GLLH0460"],"award-info":[{"award-number":["2024GLLH0480,2024GLLH0460"]}]},{"name":"Joint Scientific Research Fund Project for Public Hospitals in Inner Mongolia Autonomous Region, China","award":["2024GLLH0480,2024GLLH0460"],"award-info":[{"award-number":["2024GLLH0480,2024GLLH0460"]}]},{"name":"Baotou Health Science and Technology Program, China","award":["wsjkkj2022029"],"award-info":[{"award-number":["wsjkkj2022029"]}]},{"DOI":"10.13039\/501100004763","name":"Natural Science Foundation of Inner Mongolia Autonomous Region","doi-asserted-by":"publisher","award":["2025MS08165"],"award-info":[{"award-number":["2025MS08165"]}],"id":[{"id":"10.13039\/501100004763","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-21415-6","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T14:44:27Z","timestamp":1761662667000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Targeting SYK with miR-512-3p provides therapeutic potential in myocardial fibrosis"],"prefix":"10.1038","volume":"15","author":[{"given":"Wei","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenliang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Narigele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqin","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaojun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rina","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,28]]},"reference":[{"key":"21415_CR1","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1146\/annurev-physiol-021119-034527","volume":"82","author":"MD Tallquist","year":"2020","unstructured":"Tallquist, M. D. Cardiac fibroblast diversity. Annu. Rev. Physiol. 82, 63\u201378. https:\/\/doi.org\/10.1146\/annurev-physiol-021119-034527 (2020).","journal-title":"Annu. Rev. Physiol."},{"key":"21415_CR2","doi-asserted-by":"publisher","unstructured":"Docshin, P., Bairqdar, A. & Malashicheva, A. Interplay between BMP2 and Notch signaling in endothelial-mesenchymal transition: implications for cardiac fibrosis. Stem Cell. Investig. 10. https:\/\/doi.org\/10.21037\/sci-2023-019 (2023).","DOI":"10.21037\/sci-2023-019"},{"key":"21415_CR3","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jacc.2010.02.047","volume":"56","author":"C Jellis","year":"2010","unstructured":"Jellis, C., Martin, J., Narula, J. & Marwick, T. H. Assessment of nonischemic myocardial fibrosis. J. Am. Coll. Cardiol. 56, 89\u201397. https:\/\/doi.org\/10.1016\/j.jacc.2010.02.047 (2010).","journal-title":"J. Am. Coll. Cardiol."},{"key":"21415_CR4","doi-asserted-by":"publisher","first-page":"4195","DOI":"10.1242\/jcs.023820","volume":"123","author":"C Frantz","year":"2010","unstructured":"Frantz, C., Stewart, K. M. & Weaver, V. M. The extracellular matrix at a glance. J. Cell Sci. 123, 4195\u20134200. https:\/\/doi.org\/10.1242\/jcs.023820 (2010).","journal-title":"J. Cell Sci."},{"key":"21415_CR5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/nrcardio.2012.158","volume":"10","author":"KT Weber","year":"2013","unstructured":"Weber, K. T., Sun, Y., Bhattacharya, S. K., Ahokas, R. A. & Gerling, I. C. Myofibroblast-mediated mechanisms of pathological remodelling of the heart. Nat. Rev. Cardiol. 10, 15\u201326. https:\/\/doi.org\/10.1038\/nrcardio.2012.158 (2013).","journal-title":"Nat. Rev. Cardiol."},{"key":"21415_CR6","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1172\/JCI94753","volume":"127","author":"H Khalil","year":"2017","unstructured":"Khalil, H. et al. Fibroblast-specific TGF-beta-Smad2\/3 signaling underlies cardiac fibrosis. J. Clin. Investig. 127, 3770\u20133783. https:\/\/doi.org\/10.1172\/JCI94753 (2017).","journal-title":"J. Clin. Investig."},{"key":"21415_CR7","doi-asserted-by":"publisher","unstructured":"Murphy, A. M., Wong, A. L. & Bezuhly, M. Modulation of angiotensin II signaling in the prevention of fibrosis. Fibrogenesis Tissue Repair 8. https:\/\/doi.org\/10.1186\/s13069-015-0023-z (2015).","DOI":"10.1186\/s13069-015-0023-z"},{"key":"21415_CR8","doi-asserted-by":"publisher","first-page":"eadd4222","DOI":"10.1126\/sciadv.add4222","volume":"9","author":"L Meng","year":"2023","unstructured":"Meng, L. et al. NPRC deletion attenuates cardiac fibrosis in diabetic mice by activating PKA\/PKG and inhibiting TGF-beta1\/Smad pathways. Sci. Adv. 9, eadd4222. https:\/\/doi.org\/10.1126\/sciadv.add4222 (2023).","journal-title":"Sci. Adv."},{"key":"21415_CR9","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1111\/1744-9987.13912","volume":"27","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y. et al. miR-128-3p inhibits high-glucose-induced peritoneal mesothelial cells fibrosis via PAK2\/SyK\/TGF-beta1 axis. Therapeutic Apheresis Dialysis: Official peer-reviewed J. Int. Soc. Apheresis Japanese Soc. Apheresis Japanese Soc. Dialysis Therapy. 27, 343\u2013352. https:\/\/doi.org\/10.1111\/1744-9987.13912 (2023).","journal-title":"Therapeutic Apheresis Dialysis: Official peer-reviewed J. Int. Soc. Apheresis Japanese Soc. Apheresis Japanese Soc. Dialysis Therapy"},{"key":"21415_CR10","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.matbio.2020.04.005","volume":"91\u201392","author":"M AlQudah","year":"2020","unstructured":"AlQudah, M., Hale, T. M. & Czubryt, M. P. Targeting the renin-angiotensin-aldosterone system in fibrosis. Matrix Biology: J. Int. Soc. Matrix Biology. 91\u201392, 92\u2013108. https:\/\/doi.org\/10.1016\/j.matbio.2020.04.005 (2020).","journal-title":"Matrix Biology: J. Int. Soc. Matrix Biology"},{"key":"21415_CR11","doi-asserted-by":"publisher","unstructured":"Hada, Y., Uchida, H. A., Umebayashi, R., Yoshida, M. & Wada, J. Cilostazol attenuates AngII-Induced cardiac fibrosis in ApoE deficient mice. Int. J. Mol. Sci. 23. https:\/\/doi.org\/10.3390\/ijms23169065 (2022).","DOI":"10.3390\/ijms23169065"},{"key":"21415_CR12","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1080\/0886022X.2020.1764854","volume":"42","author":"L Liu","year":"2020","unstructured":"Liu, L. et al. miR-136 improves renal fibrosis in diabetic rats by targeting down-regulation of tyrosine kinase SYK and Inhibition of TGF-beta1\/Smad3 signaling pathway. Ren. Fail. 42, 513\u2013522. https:\/\/doi.org\/10.1080\/0886022X.2020.1764854 (2020).","journal-title":"Ren. Fail."},{"key":"21415_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jbt.22767","volume":"35","author":"S Chen","year":"2021","unstructured":"Chen, S., Zhou, H., Zhang, B., Hu, Q. & Exosomal miR-512-3p derived from mesenchymal stem cells inhibits oxidized low-density lipoprotein-induced vascular endothelial cells dysfunction via regulating Keap1. J. Biochem. Mol. Toxicol. 35, 1\u201311. https:\/\/doi.org\/10.1002\/jbt.22767 (2021).","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"21415_CR14","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.3892\/or_00000784","volume":"23","author":"F Chen","year":"2010","unstructured":"Chen, F. et al. Inhibition of c-FLIP expression by miR-512-3p contributes to taxol-induced apoptosis in hepatocellular carcinoma cells. Oncol. Rep. 23, 1457\u20131462. https:\/\/doi.org\/10.3892\/or_00000784 (2010).","journal-title":"Oncol. Rep."},{"key":"21415_CR15","doi-asserted-by":"publisher","first-page":"34790","DOI":"10.1038\/srep34790","volume":"6","author":"Y Ryu","year":"2016","unstructured":"Ryu, Y. et al. Gallic acid prevents isoproterenol-induced cardiac hypertrophy and fibrosis through regulation of JNK2 signaling and Smad3 binding activity. Sci. Rep. 6, 34790. https:\/\/doi.org\/10.1038\/srep34790 (2016).","journal-title":"Sci. Rep."},{"key":"21415_CR16","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.ijcard.2018.04.103","volume":"267","author":"RN Wu","year":"2018","unstructured":"Wu, R. N. et al. Targeting HMGB1 ameliorates cardiac fibrosis through restoring TLR2-mediated autophagy suppression in myocardial fibroblasts. Int. J. Cardiol. 267, 156\u2013162. https:\/\/doi.org\/10.1016\/j.ijcard.2018.04.103 (2018).","journal-title":"Int. J. Cardiol."},{"key":"21415_CR17","doi-asserted-by":"publisher","DOI":"10.3791\/1738","author":"JL Respress","year":"2010","unstructured":"Respress, J. L. & Wehrens, X. H. Transthoracic echocardiography in mice. J. Visualized Experiments: JoVE. https:\/\/doi.org\/10.3791\/1738 (2010).","journal-title":"J. Visualized Experiments: JoVE"},{"key":"21415_CR18","doi-asserted-by":"publisher","first-page":"197","DOI":"10.2177\/jsci.36.197","volume":"36","author":"K Chihara","year":"2013","unstructured":"Chihara, K., Kimura, Y., Honjo, C., Takeuchi, K. & Sada, K. Syk inhibitors. Japanese J. Clin. Immunol. 36, 197\u2013202. https:\/\/doi.org\/10.2177\/jsci.36.197 (2013).","journal-title":"Nihon Rinsho Men\u2019eki Gakkai kaishi = Japanese J. Clin. Immunol."},{"key":"21415_CR19","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1002\/hep.29881","volume":"68","author":"C Qu","year":"2018","unstructured":"Qu, C. et al. Tyrosine kinase SYK is a potential therapeutic target for liver fibrosis. Hepatology 68, 1125\u20131139. https:\/\/doi.org\/10.1002\/hep.29881 (2018).","journal-title":"Hepatology"},{"key":"21415_CR20","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.lfs.2016.01.023","volume":"146","author":"FY Ma","year":"2016","unstructured":"Ma, F. Y., Blease, K. & Nikolic-Paterson, D. J. A role for spleen tyrosine kinase in renal fibrosis in the mouse obstructed kidney. Life Sci. 146, 192\u2013200. https:\/\/doi.org\/10.1016\/j.lfs.2016.01.023 (2016).","journal-title":"Life Sci."},{"key":"21415_CR21","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.biocel.2016.03.001","volume":"74","author":"KH Chen","year":"2016","unstructured":"Chen, K. H. et al. Inhibition of spleen tyrosine kinase (syk) suppresses renal fibrosis through anti-inflammatory effects and down regulation of the MAPK-p38 pathway. Int. J. Biochem. Cell Biol. 74, 135\u2013144. https:\/\/doi.org\/10.1016\/j.biocel.2016.03.001 (2016).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"21415_CR22","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1038\/s41440-024-02068-w","volume":"48","author":"X Han","year":"2025","unstructured":"Han, X. et al. 4-Hydroxychalcone attenuates AngII-induced cardiac remodeling and dysfunction via regulating PI3K\/AKT pathway. Hypertens. Research: Official J. Japanese Soc. Hypertens. 48, 1054\u20131067. https:\/\/doi.org\/10.1038\/s41440-024-02068-w (2025).","journal-title":"Hypertens. Research: Official J. Japanese Soc. Hypertens."},{"key":"21415_CR23","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.yjmcc.2021.06.009","volume":"159","author":"Y Shen","year":"2021","unstructured":"Shen, Y. et al. Prostaglandin E1 attenuates AngII-induced cardiac hypertrophy via EP3 receptor activation and Netrin-1upregulation. J. Mol. Cell. Cardiol. 159, 91\u2013104. https:\/\/doi.org\/10.1016\/j.yjmcc.2021.06.009 (2021).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"21415_CR24","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1161\/CIRCULATIONAHA.106.679589","volume":"116","author":"Y Wang","year":"2007","unstructured":"Wang, Y. Mitogen-activated protein kinases in heart development and diseases. Circulation 116, 1413\u20131423. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.679589 (2007).","journal-title":"Circulation"},{"key":"21415_CR25","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.3892\/mmr.2014.2408","volume":"10","author":"R Yang","year":"2014","unstructured":"Yang, R., Chang, L., Liu, S., Jin, X. & Li, Y. High glucose induces Rho\/ROCK-dependent visfatin and type I Procollagen expression in rat primary cardiac fibroblasts. Mol. Med. Rep. 10, 1992\u20131998. https:\/\/doi.org\/10.3892\/mmr.2014.2408 (2014).","journal-title":"Mol. Med. Rep."},{"key":"21415_CR26","doi-asserted-by":"publisher","unstructured":"Li, N., Zhou, H. & Tang, Q. miR-133: A suppressor of cardiac remodeling? Front. Pharmacol. 9. https:\/\/doi.org\/10.3389\/fphar.2018.00903 (2018).","DOI":"10.3389\/fphar.2018.00903"},{"key":"21415_CR27","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.2174\/1389557523666230328125031","volume":"23","author":"M Wang","year":"2023","unstructured":"Wang, M. et al. The role of MiR-29 in the mechanism of fibrosis. Mini Rev. Med. Chem. 23, 1846\u20131858. https:\/\/doi.org\/10.2174\/1389557523666230328125031 (2023).","journal-title":"Mini Rev. Med. Chem."},{"key":"21415_CR28","doi-asserted-by":"publisher","first-page":"767064","DOI":"10.3389\/fcvm.2021.767064","volume":"8","author":"S Surina","year":"2021","unstructured":"Surina, S. et al. miR-21 in human cardiomyopathies. Front. Cardiovasc. Med. 8, 767064. https:\/\/doi.org\/10.3389\/fcvm.2021.767064 (2021).","journal-title":"Front. Cardiovasc. Med."},{"key":"21415_CR29","doi-asserted-by":"publisher","unstructured":"Eissa, M. G. & Artlett, C. M. The MicroRNA miR-155 is essential in fibrosis. Non-coding RNA 5. https:\/\/doi.org\/10.3390\/ncrna5010023 (2019).","DOI":"10.3390\/ncrna5010023"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21415-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21415-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21415-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T02:03:20Z","timestamp":1762049000000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21415-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,28]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["21415"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-21415-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,28]]},"assertion":[{"value":"15 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"37622"}}